Browse Topic
Stem Cells
-
March 29, 2022$4 million research program seeks therapy for rare genetic condition ADNP syndrome
The UC Davis MIND Institute is launching a $4 million research program aimed at finding transformative therapies for ADNP syndrome, a rare genetic condition. A group of interdisciplinary researchers will evaluate multiple gene therapies for possible use.
Read More -
March 10, 2022Cellular therapy improves signs and symptoms of Duchenne muscular dystrophy
In a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Read More
-
December 16, 2021New potential treatment for graft-versus-host-disease and other inflammatory disorders
UC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Read More
-
September 20, 2021UC President Michael Drake on campus to help induct Eye Center chairholder
UC President Michael Drake was at the UC Davis Health campus to help induct the new presidential chair in vitreoretinal science. The inaugural appointment of world-renowned physician Paul A. Sieving was held Sept. 17 with recognition of Neil and MJ Kelly and their generous donation that established the Kelly Presidential Chair in Vitreoretinal Science.
Read More
-
August 26, 2021California’s stem cell agency funds research into Angelman syndrome and bioprint pacemaker
Professors David Segal and Deborah Lieu have received Discovery Stage Research Projects awards from the California Institute for Regenerative Medicine (CIRM). The grants will fund cell gene therapy for Angelman syndrome and building the first biopacemaker
Read More
-
June 23, 2021Research provides a roadmap to HIV eradication via stem cell therapy
A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Read More
-
March 01, 2021First stem cell clinical trial for spina bifida treatment announced
A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.
Read More
-
November 12, 2020State stem cell agency funds clinical trial for spina bifida treatment
California’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.
Read More
-
September 24, 2020Spina bifida: Surgery plus stem cells before birth could improve outcomes (video)
A UC Davis Health fetal surgeon and a stem cell scientist have received approval from the U.S. Food and Drug Administration to test a one-of-a-kind spina bifida treatment that combines surgery with stem cells.
Read More -
September 08, 2020Spine center imaging system provides full-length X-ray with less radiation
UC Davis Health spine surgeons are using unique imaging technology that provides head-to-toe, 3D images of bones and is safer than other options.
Read More
-
August 17, 2020Surgical and engineering researcher wins national dialysis innovation award
Aijun Wang, a UC Davis associate professor of surgery and biomedical engineering, has been awarded a $500,000 grant to create the next generation of vascular grafts for dialysis patients with end-stage kidney disease.
Read More -
August 13, 2020UC Davis researchers find a way to help stem cells work for the heart
Blocking an enzyme — soluble epoxide hydrolase, or sEH — linked with inflammation makes it possible for stem cells to repair damaged heart tissue.
Read More -
August 12, 2020Brashear named to state stem cell agency’s governing board
School of Medicine Dean Allison Brashear is the newest board member of the state’s stem cell agency, the California Institute for Regenerative Medicine.
Read More
-
October 24, 2019Dean Allison Brashear praises clinical trials program, wants to include more patients
Dean Brashear during the UC Davis School of Medicine Office of Research Expo showcased some of the exciting research happening at the School of Medicine and called for more clinical trials to be open for patients.
Read More -
October 15, 2019In rare honor, UC Davis Health physician named as Academy Fellow of the California Academy of Sciences
On Oct. 15, UC Davis Health dermatologist and autoimmune disease specialist Emanual Maverakis will be inducted as an Academy Fellow of the California Academy of Sciences, a rare distinction for a physician.
Read More -
October 07, 2019
Cellular therapy shows promise for Duchenne muscular dystrophy
UC Davis Health researchers announced promising findings from interim results of HOPE-2 clinical trial for Duchenne muscular dystrophy.
Read More
-
July 17, 2019Q&A with stem cell expert Jan Nolta
Jan Nolta, director of UC Davis' stem cell program, answers questions about treatments and therapies using stem cells, including what people should be very cautious about when a clinic attaches a pricetag to its services.
Read More
-
August 24, 2017Stem cell treatment for children with spina bifida helps dogs first
A pair of English bulldog puppies are the first patients to be successfully treated with a unique therapy — a combination of surgery and stem cells — developed at the University of California, Davis, to help preserve lower-limb function in children with spina bifida.
Read More